Factors regulating trophoblast migration and invasiveness: Possible derangements contributing to pre-eclampsia and fetal injury

Placenta

Volumn 24, Issue 6, 2003, Pages 575-587

  Lala, P K ^a   Chakraborty, C ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN BINDING EPIDERMAL GROWTH FACTOR; SCATTER FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; UROKINASE; UROKINASE RECEPTOR;

CELL ACTIVATION; CELL INVASION; CELL MIGRATION; CLINICAL FEATURE; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; FEMALE; FETUS; FETUS DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MOLECULAR MECHANICS; MOTHER FETUS RELATIONSHIP; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TROPHOBLAST;

EID: 0141818170     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4004(03)00063-8     Document Type: Article

References (163)

1. Allaire AD, Ballenger KA, Wells SR, McMahon MJ & Lessey BA (2000) Placental apoptosis in preeclampsia. Obstet Gynecol, 96, 271-276.
2. Anim-Nyame N, Hills FA, Sooranna SR, Steer PJ & Johnson MR (2000a) A longitudinal study of maternal plasma insulin-like growth factor binding protein-1 concentrations during normal pregnancy and pregnancies complicated by preeclampsia. Hum Reprod, 15, 2215-2219.
3. Anim-Nyame N, Sooranna SR, Steer PJ & Johnson MR (2000b) Longitudinal analysis of maternal plasma leptin concentrations during normal pregnancy and preeclampsia. Hum Reprod, 15, 2033-2036.
4. Athanassiades A, Hamilton GS & Lala PK (1998) Vascular endothelial growth factor stimulates proliferation but not migration or invasiveness in human extravillous trophoblast. Biol Reprod, 59, 643-654.
5. Athanassiades A & Lala PK (1998) Role of placenta growth factor (PIGF) in human extravillous trophoblast proliferation, migration and invasiveness. Placenta, 19, 465-473.
6. Aquilina J, Barnett A, Thompson O & Harrington K (1999) Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol, 181, 131-136.
7. Arias F, Rodriquez L, Rayne SC & Kraus FT (1993) Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol, 168, 585-591.
8. Aubard Y, Darodes N & Cantaloube M (2000) Hyperhomocysteinemia and pregnancy - review of our present understanding and therapeutic implications. Eur J Obstet Gynecol Reprod Biol, 93, 157-165 Review.
9. Backe J, Bussen S & Steck T (1997) Significant decrease of maternal serum serotonin levels in singleton pregnancies complicated by the HELLP syndrome. Gynecol Endocrinol, 11, 405-409.
10. Bajoria R, Sooranna SR, Ward BS & Chatterjee R (2002) Prospective function of placental leptin at maternal-fetal interface. Placenta, 23, 103-115 Review.
11. Baker PN, Krasnow J, Roberts JM & Yeo KT (1995) Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstet Gynecol, 86, 815-821.
12. Bass KE, Morrish D, Roth I, Bhardwaj D, Taylor R, Zhou Y & Fisher SJ (1994) Human cytotrophoblast invasion is up-regulated by epidermal growth factor: evidence that paracrine factors modify this process. Dev Biol, 164, 550-561.
13. Brockelsby JC, Anthony FW, Johnson IR & Baker PN (2000) The effects of vascular endothelial growth factor on endothelial cells: a potential role in preeclampsia. Am J Obstet Gynecol, 182, 176-183.
14. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I & Baker P (1999) VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: implications in the pathogenesis of preeclampsia. Lab Invest, 79, 1101-1111.
15. Caniggia I, Grisaru-Gravnosky S, Kuliszewsky M, Post M & Lye SJ (1999) Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. J Clin Invest, 103, 1641-1650.
16. Caniggia I, Lye SJ & Cross JC (1997) Activin is a local regulator of human cytotrophoblast cell differentiation. Endocrinology, 138, 3976-3986.
17. Caniggia I, Mostachfi H, Winter J, Gassmann M, Lye SJ, Kuliszewski M & Post M (2000) Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3). J Clin Invest, 105, 577-587.
18. Caniggia I & Winter JL (2002) Hypoxia Inducible Factor-1: Oxygen Regulation of Trophoblast Differentiation in Normal and Preeclamptic Pregnancies - A Review. Placenta, 23(Suppl A), S47-S57.
19. Cartwright JE, Holden DP & Whitley GS (1999) Hepatocyte growth factor regulates human trophoblast motility and invasion: a role for nitric oxide. Br J Pharmacol, 128(1), 181-189.
20. Cartwright JE, Kenny LC, Dash PR, Crocker IP, Aplin JD, Baker PN & Whitley GS (2002) Trophoblast invasion of spiral arteries: a novel in vitro model. Placenta, 23, 232-235.
21. Chakraborty C, Gleeson LM, McKinnon T & Lala PK (2002) Regulation of human trophoblast migration and invasiveness. Can J Physiol Pharmacol, 80, 116-124. Review.
22. i and phosphorylation of MAP kinase of human extravillous trophoblast (EVT) cells. Mol Cell Endocrinol, 201, 63-73.
23. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Sherman AH, Steer PJ & Poston L (1999) Effect of antioxidants on the occurrence of preeclampsia in women at increased risk: a randomised trial. Lancet, 354, 810-816.
24. Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, Mallet A & Poston L (2002a) A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol, 187, 127-136.
25. Chappell LC, Seed PT, Kelly FJ, Briley A, Hunt BJ, Charnock-Jones DS, Mallet A & Poston L (2002b) Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol, 187, 777-784.
26. Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, Sojo I & Reyes A (2002) Maternal plasma cellular fibronectin concentrations in normal and preeclamptic pregnancies: a longitudinal study for early prediction of preeclampsia. Am J Obstet Gynecol, 187, 595-601.
27. Clausen T, Djurovic S, Brosstad FR, Berg K & Henriksen T (2000) Altered circulating levels of adhesion molecules at 18 weeks' gestation among women with eventual preeclampsia: indicators of disturbed placentation in absence of evidence of endothelial dysfunction? Am J Obstet Gynecol, 182, 321-325.
28. Clausen T, Djurovic S, Reseland JE, Berg K, Drevon CA & Henriksen T (2002) Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop preeclampsia. circulating markers of disturbed placentation? Placenta, 23, 380-385.
29. Conrad KP, Miles TM & Benyo DF (1998) Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol, 40, 102-111.
30. Craven CM, Morgan T & Ward K (1998) Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta, 19, 241-252.
31. Daniel Y, Kupferminc MJ, Baram A, Jaffa AJ, Fait G, Wolman I & Lessing JB (1998) Plasma interleukin-12 is elevated in patients with preeclampsia. Am J Reprod Immunol, 39, 376-380.
32. D'Anna R, Baviera G, Scilipoti A, Leonardi I & Leo R (2000) The clinical utility of serum uric acid measurements in preeclampsia and transient hypertension in pregnancy. Panminerva Med, 42, 101-103.
33. de Groot CJ, O'Brien TJ & Taylor RN (1996) Biochemical evidence of impaired trophoblastic invasion of decidual stroma in women destined to have preeclampsia. Am J Obstet Gynecol, 175, 24-29.
34. Dekker G & Sibai B (2001) Primary, secondary, and tertiary prevention of preeclampsia. Lancet, 357, 209-215 Review.
35. DiFederico E, Genbacev O & Fisher SJ (1999) Preeclampsia is associated with widespread apoptosis of placental cytotrophoblasts within the uterine wall. Am J Pathol, 155, 293-301.
36. Djurovic S, Schjetlein R, Wisloff F, Haugen G, Husby H & Berg K (1997) Plasma concentrations of Lp(a) lipoprotein and TGF-beta1 are altered in preeclampsia. Clin Genet, 52, 371-376.
37. Egerman RS, Andersen RN, Manejwala FM & Sibai BM (1999) Neuropeptide Y and nitrite levels in preeclamptic and normotensive gravid women. Am J Obstet Gynecol, 181, 921-923.
38. Eguchi K, Oguni N, Sawai T & Yonezawa M (1996) Comparison of plasma concentrations of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) in normal and preeclamptic pregnancies. J Perinat Med, 24, 437-443.
39. Eneroth E, Remberger M, Vahlne A & Ringden O (1998) Increased serum concentrations of interleukin-2 receptor in the first trimester in women who later developed severe preeclampsia. Acta Obstet Gynecol Scand, 77, 591-593.
40. Esplin MS, Fausett MB, Fraser A, Kerber R, Mineau G, Carrillo J & Varner MW (2001) Paternal and maternal components of the predisposition to preeclampsia. N Engl J Med, 344, 867-872.
41. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, Aznar J & Loskutoff DJ (1998) Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost, 79, 500-508.
42. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espna F, Loskutoff DJ & Schleef RR (1994) Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood, 84, 143-150.
43. Fickling SA, Williams D, Vallance P, Nussey SS & Whitley GS (1993) Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and preeclampsia. Lancet, 342, 242-243.
44. Fisher SJ, Cui TY, Zhang L, Hartman L, Grahl K, Zhang GY, Tarpey J & Damsky CH (1989) Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J Cell Biol, 109, 891-902.
45. Francoual J, Audibert F, Claise C, Chalas J, Trioche P, Frydman R & Lindenbaum A (1999) Implication of apolipoprotein E and the 1-arginine-nitric oxide system in preeclampsia. Hypertens Pregnancy, 18, 229-237.
46. Furugori K, Kurauchi O, Itakura A, Kanou Y, Murata Y, Mizutani S, Seo H, Tomoda Y & Nakamura T (1997) Levels of hepatocyte growth factor and its messenger ribonucleic acid in uncomplicated pregnancies and those complicated by preeclampsia. J Clin Endocrinol Metab, 82, 2726-2730.
47. Furuhashi N, Kimura H, Nagae H, Yajima A, Kimura C & Saito T (1993) Serum laminin levels in normal pregnancy and preeclampsia. Gynecol Obstet Invest, 36, 172-175.
48. Genbacev O, Schubach SA & Miller RK (1992) Villous culture of first trimester human placenta - model to study extravillous trophoblast (EVT) differentiation. Placenta, 13, 439-461.
49. Giudice LC, Martina NA, Crystal RA, Tazuke S & Druzin M (1997) Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth factor binding protein-I in the circulation of women with severe preeclampsia. Am J Obstet Gynecol, 176, 751-757.
50. Gleeson LM, Chakraborty C, McKinnon T & Lala PK (2001) Insulin-like growth factor-binding protein 1 stimulates human trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway. J Clin Endocrinol Metab, 86, 2484-2493.
51. Graham CH (1997) Effect of transforming growth factor-beta on the plasminogen activator system in cultured first trimester human cytotrophoblasts. Placenta, 18, 137-143.
52. Graham CH, Connelly I, MacDougall JR, Kerbel RS, Stetler-Stevenson WG & Lala PK (1994) Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp Cell Res, 214, 93-99.
53. Graham CH, Hawley TS, Hawley RG, MacDougall JR, Kerbel RS, Khoo N & Lala PK (1993) Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res, 206, 204-211.
54. Graham CH & Lala PK (1991) Mechanism of control of trophoblast invasion in situ. J Cell Physiol, 148, 228-234.
55. Graham CH, Lysiak JJ, McCrae KR & Lala PK (1992) Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod, 46, 561-572.
56. Graham CH & McCrae KR (1996) Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol, 175, 555-562.
57. Grancha S, Estelles A, Gilabert J, Chirivella M, Espana F & Aznar J (1996) Decreased expression of PAI-2 mRNA and protein in pregnancies complicated with intrauterine fetal growth retardation. Thromb Haemost, 76, 761-767.
58. Gratton RJ, Asano H & Han VK (2002) The regional expression of insulin-like growth factor II (IGF-II) and insulin-like growth factor binding protein-1 (IGFBP-1) in the placentae of women with preeclampsia. Placenta, 23, 303-310.
59. Greer IA, Lyall F, Perera T, Boswell F & Macara LM (1994) Increased concentrations of cytokines interleukin-6 and interleukin-1 receptor antagonist in plasma of women with preeclampsia: a mechanism for endothelial dysfunction. Obstet Gynecol, 84, 937-940.
60. Grobman WA & Kazer RR (2001) Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol, 97, 521-526.
61. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M & Larrea F (2000) Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1, 25-dihydroxyvitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab, 85, 1828-1833.
62. Hamilton GS, Lysiak JJ, Han VK & Lala PK (1998a) Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res, 244, 147-156.
63. Hamilton GS, Lysiak JJ, Watson AJ & Lala PK (1998b) Effects of colony stimulating factor-1 on human extravillous trophoblast growth and invasion. J Endocrinol, 159, 69-77.
64. Han VK, Bassett N, Walton J & Challis JR (1996) The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab, 81, 2680-2693.
65. Hietala R, Pohja-Nylander P, Rutanen EM & Laatikainen T (2002) Serum insulin-like growth factor binding protein-1 at 16 weeks and subsequent preeclampsia. Obstet Gynecol, 95, 185-189.
66. Holden DP, Fickling SA, Whitley GS & Nussey SS (1998) Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol, 178, 551-556.
67. Howell RJ, Economides D, Teisner B, Farkas AG & Chard T (1989) Placental proteins 12 and 14 in preeclampsia. Acta Obstet Gynecol Scand, 68, 237-240.
68. Hubel CA (1998) Dyslipidemia, iron, and oxidative stress in preeclampsia: assessment of maternal and feto-placental interactions. Semin Reprod Endocrinol, 16, 75-92 Review.
69. Hubel CA, McLaughlin MK, Evans RW, Hauth BA, Sims CJ & Roberts JM (1996) Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum. Am J Obstet Gynecol, 174, 975-982.
70. Iino K, Sjoberg J & Seppala M (1986) Elevated circulating levels of a decidual protein, placental protein 12, in preeclampsia. Obstet Gynecol, 68, 58-60.
71. Irving JA & Lala PK (1995) Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. Exp Cell Res, 217, 419-427.
72. Irving JA, Lysiak JJ, Graham CH, Hearn S, Han VK & Lala PK (1995) Characteristics of trophoblast cells migrating from first trimester chorionic villus explants and propagated in culture. Placenta, 16, 413-433.
73. Irwin JC & Giudice LC (1998) Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast alpha5beta1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures. Growth Horm IGF Res, 8, 21-31.
74. Jain SK & Wise R (1995) Relationship between elevated lipid peroxides, vitamin E deficiency and hypertension in preeclampsia. Mol Cell Biochem, 151, 33-38.
75. Kauma SW, Bae-Jump V & Walsh SW (1999) Hepatocyte growth factor stimulates trophoblast invasion: a potential mechanism for abnormal placentation in preeclampsia. J Clin Endocrinol Metab, 84, 4092-4096.
76. Khatun S, Kanayama N, Belayet HM, Bhuiyan AB, Jahan S, Begum A, Kobayashi T & Terao T (2000) Increased concentrations of plasma neuropeptide Y in patients with eclampsia and preeclampsia. Am J Obstet Gynecol, 182, 896-900.
77. Khong TY, De Wolf F, Robertson WB & Brosens I (1986) Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol, 93, 1049-1059.
78. Kilburn BA, Wang J, Duniec-Dmuchowski ZM, Leach RE, Romero R, Armant DR & Duniec-Dmuchkowski ZM (2000) Extracellular matrix composition and hypoxia regulate the expression of HLA-G and integrins in a human trophoblast cell line. Biol Reprod, 62, 739-747.
79. Kniss DA, Xie Y, Li Y, Kumar S, Linton EA, Cohen P, Fan-Havard P, Redman CW & Sargent IL (2002) ED(27) trophoblast-like cells isolated from first-trimester chorionic villi are genetically identical to HeLa cells yet exhibit a distinct phenotype. Placenta, 23, 32-43.
80. Kolben M, Lopens A, Blaser J, Huber A, Frank M, Wilhelm O, Wilhelm S, Schneider KT, Ulm K, Tschesche H, et al. (1995) Measuring the concentration of various plasma and placenta extract proteolytic and vascular factors in pregnant patients with HELLP syndrome, pre-eclampsia and highly pathologic Doppler flow values. Gynakol Geburtshilfliche Rundsch, 35(Suppl 1), 126-131.
81. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA & Socol ML (1994) Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol, 170, 1752-1757.
82. Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I & Lessing JB (1997) Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol, 38, 302-306.
83. Lain KY & Roberts JM (2002) Contemporary concepts of the pathogenesis and management of preeclampsia. JAMA, 287, 3183-3186.
84. Lala PK & Graham CG (2001) TGFB-responsive human trophoblast-derived cell lines. Placenta, 22, 889-890.
85. Lala PK & Hamilton GS (1996) Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta, 17, 545-555. Review.
86. Lala PK, Khoo NKS, Guimond M-J & Chakraborty C (1999) Control mechanisms in human trophoblast proliferation and invasiveness: their derangement during trophoblastic tumor progression. Trophoblast Res, 13, 119-136.
87. Leach RE, Khalifa R, Ramirez ND, Das SK, Wang J, Dey SK, Romero R & Armant DR (1999) Multiple roles for heparin-binding epidermal growth factor-like growth factor are suggested by its cell-specific expression during the human endometrial cycle and early placentation. J Clin Endocrinol Metab, 84, 3355-3363.
88. Leach RE, Romero R, Kim YM, Chaiworapongsa T, Kilburn B, Das SK, Dey SK, Johnson A, Qureshi F, Jacques S & Armant DR (2002) Preeclampsia and expression of heparin-binding EGF-like growth factor. Lancet, 360, 1215-1219.
89. Librach CL, Feigenbaum SL, Bass KE, Cui TY, Verastas N, Sadovsky Y, Quigley JP, French DL & Fisher SJ (1994) Interleukin-1 beta regulates human cytotrophoblast metalloproteinase activity and invasion in vitro. J Biol Chem, 269, 17125-17131.
90. Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E & Irgens LM (1998) Fetal and maternal contributions to risk of preeclampsia: population based study. BMJ, 316, 1343-1347.
91. Liu J, Chakraborty C Graham CH, Barbin YP, Dixon J & Lala PK (2003) Noncatalytic domain of uPA stimulates human extravillous trophoblast migration by utilizing phospholipase C, PI3-Kinase and MAP Kinase. Exp. Cell Res. (in press).
92. Lim KH, Friedman SA, Ecker JL, Kao L & Kilpatrick SJ (1998) The clinical utility of serum uric acid measurements in hypertensive diseases of pregnancy. Am J Obstet Gynecol, 178, 1067-1071.
93. Lindoff C & Astedt B (1994) Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markets of placental function. Am J Obstet Gynecol, 171, 60-64.
94. Lindqvist P, Grennert L & Marsal K (1999) Epidermal growth factor in maternal urine - a predictor of intrauterine growth restriction? Early Hum Dev, 56, 143-150.
95. Lowe DT (2000) Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide, 4, 441-458. Review.
96. Lyall F (2002) The human placental bed revisited. Placenta, 23, 555-562.
97. Lyall F, Simpson H, Bulmer JN, Barber A & Robson SC (2001) Transforming growth factor-beta expression in human placenta and placental bed in third trimester normal pregnancy, preeclampsia, and fetal growth restriction. Am J Pathol, 159, 1827-1838.
98. Lysiak JJ, Connelly IH, Khoo NKS, Stetler-Stevenson W & Lala PK (1994) Role of transforming growth factor-α and epidermal growth factor (EGF) on proliferation and invasion by first trimester human trophoblast. Trophoblast Res, 8, 455-467.
99. Lysiak JJ, Han VK & Lala PK (1993) Localization of transforming growth factor alpha in the human placenta and decidua: role in trophoblast growth. Biol Reprod, 49, 885-894.
100. Lysiak JJ, Hunt J, Pringle GA & Lala PK (1995) Localization of transforming growth factor beta and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta, 16, 221-231.
101. Lysiak JJ, Johnson GR & Lala PK (1995) Localization of amphiregulin in the human placenta and decidua throughout gestation: role in trophoblast growth. Placenta, 16, 359-366.
102. Malee MP, Malee KM, Azuma SD, Taylor RN & Roberts JM (1992) Increases in plasma atrial natriuretic peptide concentration antedate clinical evidence of preeclampsia. J Clin Endocrinol Metab, 74, 1095-1100.
103. Many A, Hubel CA, Fisher SJ, Roberts JM & Zhou Y (2000) Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol, 156, 321-331.
104. Many A, Hubel CA & Roberts JM (1996) Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol, 174, 288-291. Review.
105. Martin KL, Barlow DH & Sargent IL (1998) Heparin-binding epidermal growth factor significantly improves human blastocyst development and hatching in serum-free medium. Hum Reprod, 13, 1645-1652.
106. Martina NA, Kim E, Chitkara U, Wathen NC, Chard T & Giudice LC (1997) Gestational age-dependent expression of insulin-like growth factor-binding protein-1 (IGFBP-1) phosphoisoforms in human extraembryonic cavities, maternal serum, and decidua suggests decidua as the primary source of IGFBP-1 in these fluids during early pregnancy. J Clin Endocrinol Metab, 82, 1894-1898.
107. Mastrogiannis DS, O'Brien WF, Krammer J & Benoit R (1991) Potential role of endothelin-1 in normal and hypertensive pregnancies. Am J Obstet Gynecol, 165, 1711-1716.
108. McCarthy JF, Misra DN & Roberts JM (1999) Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol, 180, 731-736.
109. McCord N, Ayuk PT, Sargent IL, Redman CWG & Boyd CAR (2002) Evidence of increased oxidative stress in preeclampsia. Placenta, 23(A.39), 114.
110. McCrae KR, DeMichele AM, Pandhi P, Balsai MJ, Samuels P, Graham C, Lala PK & Cines DB (1993) Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss. Blood, 82, 2730-2741.
111. McKinnon T, Chakraborty C, Gleeson LM, Chidiac P & Lala PK (2001) Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab, 86, 3665-3674.
112. Mikkelsen AL, Schutten G, Asping U & Schutten HJ (1991) Changes in plasmaconcentration of ANP and aldosterone in normal pregnancy and pregnancy complicated by preeclampsia. Clin Exp Obstet Gynecol, 18, 185-189.
113. Mise H, Sagawa N, Matsumoto T, Yura S, Nanno H, Itoh H, Mori T, Masuzaki H, Hosoda K, Ogawa Y & Nakao K (1998) Augmented placental production of leptin in preeclampsia: possible involvement of placental hypoxia. J Clin Endocrinol Metab, 83, 3225-3229.
114. Multhaupt HA, Mazar A, Cines DB, Warhol MJ & McCrae KR (1994) Expression of urokinase receptors by human trophoblast. A histochemical and ultrastructural analysis. Lab Invest, 71, 392-400.
115. Mutlu-Turkoglu U, Aykac-Toker G, Ibrahimoglu L, Ademoglu E & Uysal M (1999) Plasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after delivery. Gynecol Obstet Invest, 48, 247-250.
116. Nelen WL (2001) Hyperhomocysteinaemia and human reproduction. Clin Chem Lab Med, 39, 758-763. Review.
117. Nishikawa S, Miyamoto A, Yamamoto H, Ohshika H & Kudo R (2000) The relationship between serum nitrate and endothelin-1 concentrations in preeclampsia. Life Sci, 67, 1447-1454.
118. Nishikawa S, Miyamoto A, Yamamoto H, Ohshika H & Kudo R (2001) Preeclamptic serum enhances endothelin-converting enzyme expression in cultured endothelial cells. Am J Hypertens, 14, 77-83.
119. Nobunaga T, Tokugawa Y, Hashimoto K, Kimura T, Matsuzaki N, Nitta Y, Fujita T, Kidoguchi KI, Azuma C & Saji F (1996) Plasma nitric oxide levels in pregnant patients with preeclampsia and essential hypertension. Gynecol Obstet Invest, 41, 189-193.
120. Norris LA, Higgins JR, Darling MR, Walshe JJ & Bonnar J (1999) Nitric oxide in the uteroplacental, fetoplacental, and peripheral circulations in preeclampsia. Obstet Gynecol, 93, 958-963.
121. Page NM, Woods RJ, Gardiner SM, Lomthaisong K, Gladwell RT, Butlin DJ, Manyonda IT & Lowry PJ (2000) Excessive placental secretion of neurokinin B during the third trimester causes preeclampsia. Nature, 405, 797-800.
122. Page NM & Lowry PJ (2001) The role of neurokinin B in preeclampsia. Hosp Med, 62, 343-346 Review.
123. Pijnenborg R (1996) The placental bed. Hypertension in Pregnancy, 15, 7-23.
124. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L & van Assche A (1991) Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol, 98, 648-655.
125. Pijnenborg R, Bland JM, Robertson WB & Brosens I (1983) Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta, 4, 397-413.
126. Pijnenborg R, Robertson WB, Brosens I & Dixon G (1981) Review article: trophoblast invasion and the establishment of haemochorial placentation in man and laboratory animals. Placenta, 2, 71-91.
127. Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR & Roberts JM (1998) Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol, 179, 1605-1611.
128. Rajkovic A, Mahomed K, Rozen R, Malinow MR, King IB & Williams MA (2000) Methylenetetrahydrofolate reductase 677 C → T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe. Mol Genet Metab, 69, 33-39.
129. Redman CW, Sacks GP & Sargent IL (1999) Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol, 180, 499-506. Review.
130. Roberts JM (1998) Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol, 16, 5-15. Review.
131. Roberts JM & Hubel CA (1999) Is oxidative stress the link in the two-stage model of preeclampsia? Lancet, 354, 788-789.
132. Roberts JM & Lain KY (2002) Recent Insights into the pathogenesis of preeclampsia. Placenta, 23, 359-372.
133. Roberts JM & Redman CW (1993) Preeclampsia: more than pregnancy-induced hypertension. Lancet, 341, 1447-1451.
134. Rust OA, Bofill JA, Zappe DH, Hall JE, Burnett JC Jr & Martin JN Jr (1997) The origin of endothelin-1 in patients with severe preeclampsia. Obstet Gynecol, 89, 754-757.
135. Rutanen EM & Seppala M (1992) Insulin-like growth factor binding protein-1 in female reproductive functions. Int J Gynaecol Obstet, 39, 3-9. Review.
136. Sanchez SE, Zhang C, Rene Malinow M, Ware-Jauregui S, Larrabure G & Williams M (2001) Plasma folate, vitamin B(12), and homocyst(e)ine concentrations in preeclamptic and normotensive Peruvian women. Am J Epidemiol, 153, 474-480.
137. Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA & Packard CJ (1997) Lipoprotein subfraction concentrations in preeclampsia: pathogenic parallels to atherosclerosis. Obstet Gynecol, 89, 403-408.
138. Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM & Wisloff F (1999) Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand, 78, 191-197.
139. Shaamash AH, Elsnosy ED, Makhlouf AM, Zakhari MM, Ibrahim OA & El-Dien HM (2000) Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, preeclampsia and eclampsia. Int J Gynaecol Obstet, 68, 207-214.
140. Shaarawy M, El Meleigy M & Rasheed K (2001) Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. J Soc Gynecol Investig, 8, 27-31.
141. Sharkey AM, Cooper JC, Balmforth JR, McLaren J, Clark DE, Charnock-Jones DS, Morris NH & Smith SK (1996) Maternal plasma levels of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by preeclampsia. Eur J Clin Invest, 26, 1182-1185.
142. Shembrey MA & Noble AD (1995) An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol, 35, 220-221.
143. Shih I, Wang T, Wu T, Kurman RJ & Gearhart JD (1998) Expression of Mel-CAM in implantation site intermediate trophoblastic cell line, IST-1, limits its migration on uterine smooth muscle cells. J Cell Sci, 111, 2655-2664.
144. Simpson H, Robson SC, Bulmer JN, Barbar A & Lyall F (2002) Transforming growth factor β expression in human placenta and placental bed during early pregnancy. Placenta, 23, 44-58.
145. Smarason AK, Allman KG, Young D & Redman CW (1997) Elevated levels of serum nitrate, a stable end product of nitric oxide, in women with preeclampsia. Br J Obstet Gynaecol, 104, 538-543.
146. Teppa RJ, Ness RB, Crombleholme WR & Roberts JM (2000) Free leptin is increased in normal pregnancy and further increased in preeclampsia. Metabolism, 49, 1043-1048.
147. Torry DS, Wang HS, Wang TH, Caudle MR & Torry RJ (1998) Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol, 179, 1539-1544.
148. Tidwell SC, Ho HN, Chin WH, Torry RJ & Torry DS (2001) Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol, 184, 1267-1272.
149. Tse WK, Whitley GS & Cartwright JE (2002) Transforming growth factor-beta1 regulates hepatocyte growth factor-induced trophoblast motility and invasion. Placenta, 23, 699-705.
150. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL & Ueland PM (2000) Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr, 71, 962-968.
151. Vural P (2002) Nitric oxide/endothelin-1 in preeclampsia. Clin Chim Acta, 317, 65-70.
152. Walker JJ (2000) Preeclampsia. Lancet, 356, 1260-1265. Review.
153. Wallukat G, Homuth V, Fischer T, Lindschau C, Horstkamp B, Jupner A, Baur E, Nissen E, Vetter K, Neichel D, Dudenhausen JW, Haller H & Luft FC (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest, 103, 945-952.
154. Wolff K, Nisell H, Carlstrom K, Kublickiene K, Hemsen A, Lunell NO & Lindblom B (1996) Endothelin-1 and big endothelin-1 levels in normal term pregnancy and in preeclampsia. Regul Pept, 67, 211-216.
155. Xu G, Chakraborty C & Lala PK (2001) Expression of TGF-beta signaling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem Biophys Res Commun, 287, 47-55.
156. Xu G, Chakraborty C & Lala PK (2002) Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells. Biochem Biophys Res Commun, 294, 1079-1086.
157. Xu G, Chakraborty C & Lala PK (2003) Reconstitution of Smad3 restores TGF-β response of tissue inhibitor of matalloprotease-1 upregulation in human choriocarcinoma cells. Biochem Biophys Res Commun, 300, 383-390.
158. Xu G, Guimond MJ, Chakraborty C & Lala PK (2002) Control of proliferation, migration, and invasiveness of human extravillous trophoblast by decorin, a decidual product. Biol Reprod, 67, 681-689.
159. Yagel S, Casper RF, Powell W, Parhar RS & Lala PK (1989) Characterization of pure human first-trimester cytotrophoblast cells in long-term culture: growth pattern, markers, and hormone production. Am J Obstet Gynecol, 160, 938-945.
160. Yagel S, Parhar RS, Jeffrey JJ & Lala PK (1988) Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells. J Cell Physiol, 136, 455-462.
161. Zdravkovic M, Aboagye-Mathiesen G, Guimond MJ, Hager H, Ebbesen P & Lala PK (1999) Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells. Placenta, 20, 431-440.
162. Zhou Y, Damsky CH & Fisher SJ (1997) Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? J Clin Invest, 99, 2152-2164.
163. Zhou Y, Fisher SJ, Janatpour M, Genbacev O, Dejana E, Wheelock M & Damsky CH (1997) Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest, 99, 2139-2151.